COMMUNIQUÉS West-GlobeNewswire

Meridian Bioscience Reports Second Quarter 2019 Operating Results, Suspends Quarterly Cash Dividend, and Provides Fiscal 2019 Guidance for Pending Acquisition

30/04/2019 - 15:42

CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter and first six months ended March 31, 2019. Second Quarter 2019 Highlights [...]

Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform

30/04/2019 - 15:41

CINCINNATI, April 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has entered into a definitive [...]

Mapi Pharma to Present Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at the 2019 AAN Annual Meeting in Philadelphia on May 7 2019

30/04/2019 - 15:39

81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 years NESS ZIONA, Israel, April 30, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development [...]

Shineco, Inc. Enters into Strategic Cooperation Frame Agreement with Life Spectacular, Inc. to Establish NewHemp North American Cosmeceutical Laboratory

30/04/2019 - 15:30

The Company aims to explore opportunities in the beauty market BEIJING, April 30, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines [...]

JSC Olainfarm Corporate Governance Report 2018

30/04/2019 - 15:22

JSC Olainfarm hereby publishes its Corporate Governance Report for the reporting year of 2018. Information prepared by: Jānis Dubrovskis Investor Relations Advisor of JSC Olainfarm Ph.: +371 29178878 janis.dubrovskis@ [...]

Ventura Cannabis Releases Updated Investor Presentation to Website; Provides Conference Call Details

30/04/2019 - 15:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, April 30, 2019 (GLOBE NEWSWIRE) -- Ventura [...]

SetPoint Medical to Present at Bank of America Merrill Lynch Health Care Conference 2019

30/04/2019 - 15:00

VALENCIA, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, announced today that Murthy Simhambhatla, Ph.D [...]

MannKind Corporation to Hold 2019 First Quarter Financial Results Conference Call on May 7, 2019

30/04/2019 - 15:00

WESTLAKE VILLAGE, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2019 first quarter financial results on Tuesday, May 7, 2019 and its management will host a conference [...]

Predictive Technology Group Completes Integration of Taueret Laboratories and Inception Dx into its Subsidiary, Predictive Laboratories

30/04/2019 - 15:00

SALT LAKE CITY, April 30, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through [...]

Fluidigm Announces 8th Annual Mass Cytometry Summit

30/04/2019 - 15:00

Fluidigm invites researchers to the world’s largest global mass cytometry conference in Vancouver, Canada SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative [...]

Wildflower’s Acquisition of City Cannabis to Include Cambie Street Location

30/04/2019 - 15:00

VANCOUVER, British Columbia, April 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is excited to announce that the City of Vancouver has approved and issued [...]

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019

30/04/2019 - 14:45

LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first quarter 2019 ended March 31 [...]

Oncology Venture prolongs subscription period

30/04/2019 - 14:30

Press release Hørsholm, Denmark April 30, 2019 – Oncology Venture A/S has decided to extent the subscription period in current rights issue. Rights issue In light of the clinical news published in press release today [...]

Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program

30/04/2019 - 14:30

OCALA, Fla., April 30, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc., an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, [...]

Allogene Therapeutics to Report First Quarter 2019 Financial Results on May 7, 2019

30/04/2019 - 14:30

Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company [...]

Latest Wound Care Research from Organogenesis Highlighted at SAWC Spring 2019

30/04/2019 - 14:30

CANTON, Mass. and SAN ANTONIO, April 30, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of [...]

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

30/04/2019 - 14:30

Mavacamten is Being Developed to Treat the Most Common Inherited Form of Heart Disease, Hypertrophic Cardiomyopathy, for Which No Targeted Medical Therapies Exist Twelve-Week Treatment with Mavacamten Demonstrated [...]

Ultragenyx to Host Conference Call for First Quarter 2019 Financial Results and Corporate Update

30/04/2019 - 14:30

NOVATO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]

Auris Medical Announces Reverse Stock Split

30/04/2019 - 14:30

Hamilton, Bermuda, April 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology [...]